Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study

Background and Objectives: The treatment of chronic lymphocytic leukemia (CLL) has acquired new targeted therapies. In clinical trials, ibrutinib improved outcomes safely. Real-world data called for a reappraisal of ibrutinib strategies. We report on a single center’s experience with ibrutinib monot...

Descripción completa

Detalles Bibliográficos
Autores principales: Moldovianu, Ana-Maria, Stoia, Razvan, Vasilica, Mariana, Ursuleac, Iulia, Badelita, Sorina Nicoleta, Tomescu, Andra Alina, Preda, Oana Diana, Bardas, Alexandru, Cirstea, Mihaela, Coriu, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959500/
https://www.ncbi.nlm.nih.gov/pubmed/36837525
http://dx.doi.org/10.3390/medicina59020324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959500/
https://www.ncbi.nlm.nih.gov/pubmed/36837525
http://dx.doi.org/10.3390/medicina59020324

Ejemplares similares